Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | FCN | SEB |
|---|---|---|
| Price | $138.02 | $3,978.74 |
| Change today | ▲ 1.19% | ▼ 1.13% |
| Market cap | $3.81B | $3.81B |
| Return, 3 months | -12.9% | -10.6% |
| Return, year to date | -19.2% | -10.4% |
| Return, 1 year | -14.3% | +13.4% |
| P/E (TTM) | 16.7 | 6.0 |
| P/B | 2.9 | 0.7 |
| P/E percentile vs own 5y | 1st | – |
| Dividend yield | – | 0.23% |
| Revenue growth (YoY, latest qtr) | – | +7.1% |
| Net profit growth (YoY) | – | +456.7% |
| Gross margin | – | 8.1% |
| Operating margin | – | 3.4% |
| Net margin | – | 6.2% |
| Return on equity | – | 12.3% |
| Analyst target vs. price | +19.9% | – |
| Analyst buy share | 33% | – |
| RSI (14) | 44 | 40 |
| 30-day volatility | 32.3% | 30.8% |
| Max drawdown, 1 year | -30.3% | -34.3% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
